INTRODUCTION AND OBJECTIVES:
The FDA approved da Vinci SP (Intuitive Surgical, Sunnyvale, CA) surgical system was developed specifically to facilitate single-site surgery, with the ideal aim to further reduce the invasiveness. We aimed to describe the technique of pure single-site trans-peritoneal robotic partial nephrectomy using the novel da Vinci SP surgical system. METHODS: Three consecutive patients who were diagnosed with contrast-enhanced renal masses amenable of partial nephrectomy were counseled and accepted to undergo robot-assisted partial nephrectomy performed by using the SP Surgical System. Data collection received institutional review board approval . Subjects were provided with informed consent explaining the adoption of the novel surgical platform. The procedures were performed by reproducing the steps of the standard institutional multi-arms robotic approach to partial nephrectomy.
RESULTS: The surgeries were successfully performed. There was no need for conversion to standard multi-ports robotic approach nor need for additional ports placement. All the procedures were completed according to a pure single-site approach (no extra transabdominal ports were placed). No intraoperative complications occurred. The total robotic operative time averaged 180 min. The warm ischemia time averaged 25 min. Blood loss averaged 180 mL. All patients had negative parenchymal margins.
CONCLUSIONS: The feasibility of pure single-site transperitoneal robot-assisted partial nephrectomy using the novel SP surgical system is reported herein. Further studies are needed to confirm our results on a larger sample size. Comparative studies versus standard multiport robotic surgery are awaited.
Source of Funding: None.
V08-02 OFFICE-BASED, ULTRASOUND-GUIDED RENAL MASS BIOPSY: TECHNIQUE AND RESULTS
Francis Jefferson*, Zhamshid Okhunov, John Sung, Courtney Cottone, Roshan Patel, Jaime Landman, Orange, CA INTRODUCTION AND OBJECTIVES: Imaging advances have led to an increase in the incidental detection of small renal masses (SRM) (i.e. 4 cm) and, perforce, of renal cell carcinoma (RCC). Notably, 20% of SRM are benign, and some indolent malignant tumors can be safely managed with active surveillance; yet, pre-excision biopsy is practiced by a minority of urologists. Renal mass biopsy (RMB) could alter the management of SRM by reducing the number of benign masses excised. Historically, RMB required patient sedation, CT-guidance, and was a radiologist-performed, hospitalbased procedure. Advances in ultrasound (US) technology now enable the urologist to perform office-based, US-guided RMB. This video presentation details our office-based, US-guided RMB technique in an 80-year-old male with a renal mass and provides further details on our experience with this approach in over 50 patients.
METHODS: A few hours prior to the scheduled biopsy, the patient applies anesthetic cream (lidocaine 2.5% / prilocaine 2.5%) to the skin overlying the previously outlined biopsy entry point. The patient positions himself/herself in the prone position. Once the target lesion and renal anatomy are identified on US, 1% lidocaine is injected into the skin and along the entire biopsy needle track up to a few mm off the surface of the tumor. A standard 18G biopsy gun is used to insert a biopsy needle under direct US-guided vision using a facilitated US targeting system; 4-6 cores are obtained. After the procedure, the patient's vital signs are monitored; one hour after the biopsy, a Doppler US is performed in the office to assess for complications. The patient is evaluated for pain (scale 0-10) before and after the biopsy, and a follow-up appointment is made in order to discuss the biopsy results.
RESULTS: Our prospectively maintained RMB database (N[52) revealed a diagnostic rate of 73% and a concordance with final pathology in 100% (16/16) for primary histology, 93% (14/15) for histologic subtype, and 90% (9/10) for low (I-II) vs. high (III-IV) Fuhrman grade. RMB revealed benign pathology in 21% (11/52) of patients. No patient with a benign lesion underwent surgery. Of note, 39% (20/52) of our patients have opted for active surveillance. There were no complications. Patients reported a median pain score of 1/10 (range 0-5) and 0/10 (range 0-5.5) immediately after RMB and at one hour after RMB, respectively. Fewer than 10% (4/52) of patients required narcotics for pain.
CONCLUSIONS: Office-based RMB can safely be performed by a urologist skilled in renal ultrasonography. RMB guides patient management and markedly reduces the rate of surgery for benign renal masses.
Source of Funding: none

V08-03 TECHNIQUES FOR DEALING WITH HEMORRHAGE DURING ROBOTIC ASSISTED RENAL TUMOR THROMBECTOMY FOR IVC RENAL TUMOR THROMBUS
Amit Patel*, Taylor Poloskey, Craig Rogers, Detroit, MI INTRODUCTION AND OBJECTIVES: Open radical nephrectomy with inferior vena cava (IVC) thrombectomy has been considered to be the preferred treatment for renal cell carcinoma with IVC thrombus, due to clinician concern over management of hemorrhage. In this video, we highlight surgical tips and tricks for robotic caval renal tumor thrombectomy to manage bleeding safely.
METHODS: 57 year old woman, with a right sided 7x7.5x6.5 cm renal mass,with evidence of renal vein and IVC thrombus extending 2cm cranially, underwent right robotic assisted radical nephrectomy. In the video the following surgical techniques were highlighted to prevent bleeding during the IVC thrombectomy: early ligation of renal artery, use of doppler for visualisation of thrombus extent, ICG guidance for kidney perfusion, division of short hepatics for greater cranial IVC exposure and utilisation of slings.
RESULTS: The techniques for management of unforeseen intraoperative bleeding during cavotomy included the following: test venotomy of the gonadal vein stump with re-clipping as needed for bleeding, further retrocaval dissection and division of lumbar veins and renal artery to allow greater mobilization of the IVC to help identify a previously missed gonadal vein, use of bulldog clamps in addition to slings, lateral kidney mobilisation and division of ureter/ gonadal vessel tissue to ensure no accessory inflow. Bleeding was abated and the procedure was completed without complication. Blood loss was 300cc. The patient suffered with a Clavien 2 complication (antibiotics for community acquired lower respiratory tract infection) delaying discharge to day 6. Histology revealed clear cell RCC, 7cm, grade3, pT3bN0.
CONCLUSIONS: Management strategies for intraoperative bleeding complications, during cavotomy and thrombus excision, allow for safe utilisation of robotic techniques in renal tumour thrombus surgery.
